BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2015 11:06:00 AM | Browse: 1333 | Download: 1949
 |
Received |
|
2014-06-20 09:11 |
 |
Peer-Review Started |
|
2014-06-20 16:19 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-07-28 16:18 |
 |
Revised |
|
2014-08-27 02:21 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-09-30 10:03 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-09-30 10:29 |
 |
Articles in Press |
|
2014-09-30 10:56 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-12-24 21:05 |
 |
Publish the Manuscript Online |
|
2015-01-07 11:07 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Moran Lavie, Tzipora Manovitz, Daphna Vilozni, Sarina Levy-Mendelovich, Ifat Sarouk, Ilana Weintraubv, David Shoseyov, Malena Cohen-Cymberknoh, Joseph Rivlin and Ori Efrati |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Moran Lavie, Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Derech Sheba 2, Tel Hashomer 52621, Israel. moran.lavie@sheba.health.gov.il |
| Key Words |
Distal intestinal obstruction syndrome; Cystic fibrosis; Meconium ileus; Treatment; Recurrence |
| Core Tip |
Distal intestinal obstruction syndrome (DIOS) is a gastrointestinal complication of cystic fibrosis (CF). This study reviews the long-term follow-up of DIOS across two decades in Israeli CF patients. The DIOS patients were more prone to meconium ileus, Aspergillus spp. airway colonization and frequent hospitalizations then the DIOS-negative CF patients. DIOS recurrence was observed in 77% of patients. Conservative treatment was successful in 82% of the episodes, which makes it the treatment of choice for DIOS management. The survival rate was similar to the CF patients without DIOS. |
| Publish Date |
2015-01-07 11:07 |
| Citation |
Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I, Shoseyov D, Cohen-Cymberknoh M, Rivlin J, Efrati O. Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis. World J Gastroenterol 2015; 21(1): 318-325 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i1/318.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i1.318 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.